AVROBIO Inc reports results for the quarter ended in December - Earnings Summary

Reuters03-21

* AVROBIO Inc reported a quarterly adjusted loss of 20 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -57 cents. The mean expectation of three analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -50 cents to -15 cents per share.

* Reported revenue was zero; analysts expected zero.

* AVROBIO Inc's reported EPS for the quarter was a loss of 20 cents.

* The company reported a quarterly loss of $8.79 million.

* AVROBIO Inc shares had fallen by 5.9% this quarter.

FORECAST CHANGES

* The mean earnings estimate of analysts had risen by about 12.6% in the last three months.

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* Wall Street's median 12-month price target for AVROBIO Inc is $2.00

This summary was machine generated from LSEG data March 21 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Dec. 31 2023 -0.34 -0.20 Beat

Sep. 30 2023 -0.28 -0.44 Missed

Jun. 30 2023 -0.07 -0.37 Missed

Mar. 31 2023 -0.54 -0.57 Missed

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2421604315?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-21 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2421604315","market":"us","top_or_hot":-1,"title":"AVROBIO Inc reports results for the quarter ended in December - Earnings Summary","media":"Reuters","content":"<html><body><p>* AVROBIO Inc    reported a quarterly adjusted loss of 20 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -57 cents.  The mean expectation of three analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -50 cents to -15 cents per share.</p><p>   * Reported revenue was zero; analysts expected zero. </p><p>   * AVROBIO Inc's reported EPS for the quarter was a loss of 20 cents.</p><p>   * The company reported a quarterly loss of $8.79 million.</p><p>   * AVROBIO Inc shares had fallen by 5.9% this quarter.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts had risen by about 12.6% in the last three months. </p><p>   * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * Wall Street's median 12-month price target for AVROBIO Inc is $2.00 </p><p>This summary was machine generated from LSEG data March 21 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Dec. 31 2023      -0.34          -0.20          Beat</p><p>Sep. 30 2023      -0.28          -0.44          Missed</p><p>Jun. 30 2023      -0.07          -0.37          Missed</p><p>Mar. 31 2023      -0.54          -0.57          Missed</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AVROBIO Inc reports results for the quarter ended in December - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAVROBIO Inc reports results for the quarter ended in December - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-21 21:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* AVROBIO Inc    reported a quarterly adjusted loss of 20 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -57 cents.  The ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2421604315","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2421604315","pubTimestamp":1711027890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* AVROBIO Inc    reported a quarterly adjusted loss of 20 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -57 cents.  The me","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"AVROBIO Inc。报告截至12月的季度业绩——收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVRO":0.9},"content_text":"* AVROBIO Inc    reported a quarterly adjusted loss of 20 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -57 cents.  The mean expectation of three analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -50 cents to -15 cents per share.   * Reported revenue was zero; analysts expected zero.    * AVROBIO Inc's reported EPS for the quarter was a loss of 20 cents.   * The company reported a quarterly loss of $8.79 million.   * AVROBIO Inc shares had fallen by 5.9% this quarter.FORECAST CHANGES   * The mean earnings estimate of analysts had risen by about 12.6% in the last three months.    * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONS   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"    * Wall Street's median 12-month price target for AVROBIO Inc is $2.00 This summary was machine generated from LSEG data March 21 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDDec. 31 2023      -0.34          -0.20          BeatSep. 30 2023      -0.28          -0.44          MissedJun. 30 2023      -0.07          -0.37          MissedMar. 31 2023      -0.54          -0.57          Missed","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2421604315"}